Clopidogrel

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Clopidogrel and local guidelines before prescribing.

Antiplatelet (P2Y12 inhibitor)

Mechanism

Irreversible P2Y12 platelet receptor antagonist (prodrug activated by CYP2C19).

Uses

ACS, after stent, secondary prevention after stroke, peripheral arterial disease.

Dosing

4 more dose entries from the chapters

Side effects

Bleeding, dyspepsia, rash; rarely TTP.

Interactions

Omeprazole and esomeprazole reduce activation (use pantoprazole instead); anticoagulants and NSAIDs increase bleeding.

Contraindications and cautions

Active bleeding, severe liver disease

Monitoring

Bleeding; hold 5–7 days before elective surgery

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

No adjustment

Overdose and reversal

Platelet transfusion for bleeding

Special advice

Stop 5 to 7 days before elective surgery where possible; poor CYP2C19 metabolisers have less benefit.

More from the textbook: uses, cautions and other points
Where it is discussed in the book